List your company on Longevity Club — free.

Put your products in front of thousands of active longevity customers.

Claim free listing

DNAtriX Company

DNAtriX is a biotechnology company developing an oncolytic virus platform for treating malignant glioma.

Investors

Total Funding: $57 084 013
Last Funding Type: Venture - Series Unknown
Industry: Women Cancer Treatment
Estimated Revenue: $500M to $1B
Founded Date: 2005-01-01
Last Funding Date: 2018-09-12
Headquarters: Houston, Texas, United States
Register and Claim Ownership